Cardiac tamponade as an unusual initial presentation of squamous cell carcinoma of the esophagus
1Department of Emergency Medicine, Faculty of Medicine, Chiang Mai University, 50200 Chiang Mai, Thailand
DOI: 10.22514/sv.2021.120 Vol.18,Issue 6,November 2022 pp.110-113
Submitted: 10 May 2021 Accepted: 01 June 2021
Published: 08 November 2022
Pericardial effusions leading to cardiac tamponade have previously been described with esophageal cancer. However, up to eighty percent of these cases have been reported in association with chemotherapy and radiation. Patients with esophageal cancer seldom initially present with pericardial effusion resulting from esophageal pericardial fistula (EPF). Herein, we present the case of a 62-year-old man who presented with pericardial effusion with an unknown etiology at presentation. Subsequently, the patient developed cardiac tamponade and was referred to the tertiary hospital for further evaluation. Computed tomography of the chest revealed a circumferential irregular enhancing lesion at the mid-thoracic esophagus suspecting esophageal cancer with EPF and a moderate amount of pericardial effusion. The patient underwent esophagoscopy and squamous cell carcinoma was found from the esophageal biopsy. An esophageal stent was successfully placed to conceal the perforation. Eventually, the patient died 13 days after admission complicated by refractory septic shock. This case highlights an atypical presentation of esophageal cancer and an unusual cause of cardiac tamponade.
Cardiac tamponade; Esophageal cancer; Pericardial effusion; Esophagus; Esophageal pericardial fistula
Nitchakarn Hongsuphan,Saowaluck Faikongngeon,Wachira Wongtanasarasin. Cardiac tamponade as an unusual initial presentation of squamous cell carcinoma of the esophagus. Signa Vitae. 2022. 18(6);110-113.
 Adler Y, Charron P. The 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. European Heart Journal. 2015; 36: 2873–2874.
 Abdullah HMA, Khan UI, Wasekar C, Omar M. Cardiac tamponade and purulent pericarditis secondary to an oesophageal pericardial fistula as an initial presentation of squamous cell carcinoma of the oesophagus. BMJ Case Reports. 2019; 12: e229634.
 Saluja SS, Puri SK, Arora A, Chander Sharma B, Mishra PK. Esophagopericardial fistula: a delayed complication after esophageal stenting. the American Surgeon. 2013; 79: 550–552.
 Touati GD, Carmi D, Nzomvuama A, Marticho P. Purulent pericarditis caused by malignant oesophago-pericardial fistula. European Journal of Cardio-Thoracic Surgery. 2003; 24: 847–849.
 Kaufman J, Thongsuwan N, Stern E, Karmy-Jones R. Esophageal-pericardial fistula with purulent pericarditis secondary to esophageal carcinoma presenting with tamponade. The Annals of Thoracic Surgery. 2003; 75: 288–289.
 Tombazzi C, Marino G, Yong J, Vallejo V, Reddy K. Malignant esophageal pericardial fistula presenting as cardiac tamponade. Digestive Diseases and Sciences. 2006; 51: 1290–1293.
 Kariyanna PT, Jayarangaiah A, Pedalino R, Hegde S, Marmur JD, Shenoy A, et al. Esophago-pericardial Fistula Induced Community Acquired Methicillin Resistant Staphylococcus Aureus (CA-MRSA) Cardiac Tamponade—a Rare Case Report and Literature Review. American Journal of Medical Case Reports. 2018; 6: 109–113.
 Wang M-C, Huang B-H, Kok VC. Esophagopericardial fistula and purulent pericarditis causing cardiac tamponade during concurrent chemoradiotherapy for esophageal cancer: A case report. Therapeutic Radiology and Oncology. 2017; 24: 67–75.
 Chen R, Zheng RS, Zhang SW, Zeng HM, Wang SM, Sun KX, et al. Analysis of incidence and mortality of esophageal cancer in China, 2015. Zhonghua Yu Fang Yi Xue Za Zhi. 2019; 53: 1094–1097. (In Chinese)
 Zarean E, Mahmoudi M, Azimi T, Amini P. Determining Overall Survival and Risk Factors in Esophageal Cancer Using Censored Quantile Regression. Asian Pacific Journal of Cancer Prevention. 2018; 19: 3081–3086.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 0.5(2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.